CCM
HPTX

Consonance Capital Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Consonance Capital Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,901,930
Closed -$87.3M – 32
2015
Q1 		$87.3M Buy
1,901,930
+650,577
+52% +$19.5M 7.95% 3
2014
Q4 		$30M Sell
1,251,353
-11,681
-0.9% -$263K 3.87% 12
2014
Q3 		$31.9M Sell
1,263,034
-16,014
-1% -$398K 4.37% 10
2014
Q2 		$33.4M Buy
1,279,048
+252,956
+25% +$6.5M 4.97% 9
2014
Q1 		$26.5M Buy
1,026,092
+291,796
+40% +$7.91M 3.94% 13
2013
Q4 		$14.8M Buy
734,296
+651,154
+783% +$15.3M 2.43% 19
2013
Q3 		$2.17M Buy
+83,142
New +$2.08M 0.54% 24

Consonance Capital Management's HPTX Position: Q2 2015 in Review

Consonance Capital Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 1,901,930 shares — an estimated $87.3M sold.

Consonance Capital Management first reported a position in HPTX in Q3 2013 and held it in 7 quarters. The position peaked at $87.3M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Consonance Capital Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Consonance Capital Management sold 1,901,930 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $87.3M.
  • Consonance Capital Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 7 quarters.
  • Consonance Capital Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $87.3M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Consonance Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.